BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1716511)

  • 21. The combination of laser recanalization and endoluminal intubation in the palliation of malignant dysphagia.
    Cottier DJ; Carter CR; Smith JS; Anderson JR
    J R Coll Surg Edinb; 1997 Feb; 42(1):19-20. PubMed ID: 9046137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life.
    Madhusudhan C; Saluja SS; Pal S; Ahuja V; Saran P; Dash NR; Sahni P; Chattopadhyay TK
    Dis Esophagus; 2009; 22(4):331-6. PubMed ID: 19473211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nd-YAG laser as a palliative treatment for malignant dysphagia.
    Maciel J; Barbosa J; Leal AS
    Eur J Surg Oncol; 1996 Feb; 22(1):69-73. PubMed ID: 8846872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroesophageal reflux disease-related symptom assessment in subjects with malignant dysphagia receiving esophageal stents.
    North DA; Schlegel M; Martin RC
    Am Surg; 2014 Dec; 80(12):1260-5. PubMed ID: 25513927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic Nd:YAG laser therapy of malignant esophageal obstruction on an outpatient basis.
    Ferraro P; Beauchamp G; Aumais G
    Can J Surg; 1990 Dec; 33(6):479-82. PubMed ID: 1701341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective randomized clinical trial comparing brachytherapy and laser photoablation for palliation of esophageal cancer.
    Low DE; Pagliero KM
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):173-8; discussion 178-9. PubMed ID: 1377311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limitations of laser treatment for malignant dysphagia.
    Ackroyd R; Hosie KB; Paraskevopoulos JA; Stoddard CJ
    Br J Surg; 1992 Dec; 79(12):1383. PubMed ID: 1283108
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects and outcomes after palliative surgical treatment of malignant dysphagia.
    Søreide JA; Grønbech JE; Mjåland O
    Scand J Gastroenterol; 2006 Apr; 41(4):376-81. PubMed ID: 16635903
    [No Abstract]   [Full Text] [Related]  

  • 29. Esophageal stents in malignant dysphagia: a two-edged sword?
    Neale JC; Goulden JW; Allan SG; Dixon PD; Isaacs RJ
    J Palliat Care; 2004; 20(1):28-31. PubMed ID: 15132073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma.
    Blazeby JM; Farndon JR; Donovan J; Alderson D
    Cancer; 2000 Apr; 88(8):1781-7. PubMed ID: 10760752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric-Esophageal Stenting for Malignant Dysphagia: Results of Prospective Clinical Trial Evaluation of Long-Term Gastroesophageal Reflux and Quality of Life-Related Symptoms.
    Philips P; North DA; Scoggins C; Schlegel M; Martin RC
    J Am Coll Surg; 2015 Jul; 221(1):165-73. PubMed ID: 26095567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fully covered stents are similar to semi-covered stents with regard to migration in palliative treatment of malignant strictures of the esophagus and gastric cardia: results of a randomized controlled trial.
    Persson J; Smedh U; Johnsson Å; Ohlin B; Sundbom M; Nilsson M; Lundell L; Sund B; Johnsson E
    Surg Endosc; 2017 Oct; 31(10):4025-4033. PubMed ID: 28236016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliative therapy for esophageal cancer: laser therapy alone is associated with a better functional outcome.
    Pozza A; Erroi FR; Scarpa M; Polese L; Rampazzo L; Norberto L
    Updates Surg; 2015 Mar; 67(1):61-7. PubMed ID: 25627110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Palliative treatment of malignant dysphagia].
    Aujeský R; Král V; Neoral C; Klein J; Klementa I
    Rozhl Chir; 1996 Feb; 75(2):76-80. PubMed ID: 8768964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction.
    Vakil N; Morris AI; Marcon N; Segalin A; Peracchia A; Bethge N; Zuccaro G; Bosco JJ; Jones WF
    Am J Gastroenterol; 2001 Jun; 96(6):1791-6. PubMed ID: 11419831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and management of laser-associated oesophageal perforation.
    Tyrrell MR; Trotter GA; Adam A; Mason RC
    Br J Surg; 1995 Sep; 82(9):1257-8. PubMed ID: 7552012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-expanding metal stents for malignant esophagogastric obstruction: experience with a new design covered nitinol stent.
    Keller R; Flieger D; Fischbach W; Christl SU
    J Gastrointestin Liver Dis; 2007 Sep; 16(3):239-43. PubMed ID: 17925915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laser palliation of esophageal carcinoma.
    Monga A; Kumar D; Jain SK
    J Assoc Physicians India; 2002 Aug; 50():1017-21. PubMed ID: 12421022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The YAG laser and Wallstent endoprosthesis for palliation of cancer in the esophagus or gastric cardia.
    Tranberg KG; Stael von Holstein C; Ivancev K; Cwikiel W; Lunderquist A
    Hepatogastroenterology; 1995 Apr; 42(2):139-44. PubMed ID: 7545639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An antireflux stent versus conventional stents for palliation of distal esophageal or cardia cancer: a randomized clinical study.
    Wenger U; Johnsson E; Arnelo U; Lundell L; Lagergren J
    Surg Endosc; 2006 Nov; 20(11):1675-80. PubMed ID: 16960663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.